Functional genomics of the human high-density lipoprotein receptor scavenger receptor BI: An old dog with new tricks

Current Opinion in Endocrinology, Diabetes and Obesity

Volumn 20, Issue 2, 2013, Pages 124-131

  Chadwick, Alexandra C ^a   Sahoo, Daisy ^b  

^a Division of Endocrinology   (United States)

^b MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

Fertility; HDL cholesterol; Platelets; Scavenger receptor BI; Steroidogenesis

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; SCAVENGER RECEPTOR BI;

ADRENAL FUNCTION; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CHOLESTEROL TRANSPORT; DNA POLYMORPHISM; FEMALE FERTILITY; FUNCTIONAL GENOMICS; GENE LOCUS; GENETIC VARIABILITY; HETEROZYGOTE; HUMAN; HYPERLIPIDEMIA; IN VITRO STUDY; INTRON; LIPID ANALYSIS; LIPID METABOLISM; LIVER CELL; MACROPHAGE; NONHUMAN; OLIGOMERIZATION; PROTEIN EXPRESSION; REVIEW; STEROIDOGENESIS; THROMBOCYTE FUNCTION; THROMBOCYTE LIFESPAN; THROMBOCYTOPENIA;

ATHEROSCLEROSIS; FEMALE; FERTILITY; HUMANS; LIPIDS; LIPOPROTEINS, HDL; MALE; MUTATION; PLATELET ACTIVATION; POLYMORPHISM, SINGLE NUCLEOTIDE; SCAVENGER RECEPTORS, CLASS B;

EID: 84874949459     PISSN: 1752296X     EISSN: 17522978     Source Type: Journal    
DOI: 10.1097/MED.0b013e32835ed575     Document Type: Review

References (122)

1. Krieger M. Charting the fate of the 'good cholesterol': identification and characterization of the high-density lipoprotein receptor SR-BI. Annu Rev Biochem 1999; 68:523-558.
2. Acton S, Rigotti A, Landschulz KT, et al. Identification of scavenger receptor SR-BI as a high density lipoprotein receptor. Science 1996; 271:518-520.
3. Acton SL, Scherer PE, Lodish HF, Krieger M. Expression cloning of SR-BI, a CD36-related class B scavenger receptor. J Biol Chem 1994; 269:21003-21009.
4. Rosenson RS, Brewer HB Jr, Davidson WS, et al. Cholesterol efflux and atheroprotection: advancing the concept of reverse cholesterol transport. Circulation 2012; 125:1905-1919.
5. Brundert M, Ewert A, Heeren J, et al. Scavenger receptor class B type I mediates the selective uptake of high-density lipoprotein-associated cholesteryl ester by the liver in mice. Arterioscler Thromb Vasc Biol 2005; 25:143-148.
6. Out R, Hoekstra M, Spijkers JA, et al. Scavenger receptor class B type I is solely responsible for the selective uptake of cholesteryl esters from HDL by the liver and the adrenals in mice. J Lipid Res 2004; 45:2088-2095.
7. Ji Y, Wang N, Ramakrishnan R, et al. Hepatic scavenger receptor BI promotes rapid clearance of high density lipoprotein free cholesterol and its transport into bile. J Biol Chem 1999; 274:33398-33402.
8. Ueda Y, Royer L, Gong E, et al. Lower plasma levels and accelerated clearance of high density lipoprotein (HDL) and non-HDL cholesterol in scavenger receptor class B type I transgenic mice. J Biol Chem 1999; 274:7165-7171.
9. Wang N, Arai T, Ji Y, et al. Liver-specific overexpression of scavenger receptor BI decreases levels of very low density lipoprotein apoB, low density lipoprotein apoB, and high density lipoprotein in transgenic mice. J Biol Chem 1998; 273:32920-32926.
10. Kozarsky KF, Donahee MH, Rigotti A, et al. Overexpression of the HDL receptor SR-BI alters plasma HDL and bile cholesterol levels. Nature 1997; 387:414-417.
11. Webb NR, De Beer MC, Yu J, et al. Overexpression of SR-BI by adenoviral vector promotes clearance of apoA-I, but not apoB, in human apoB transgenic mice. J Lipid Res 2002; 43:1421-1428.
12. Varban ML, Rinninger F, Wang N, et al. Targeted mutation reveals a central role of SR-BI in hepatic selective uptake of high density lipoprotein cholesterol. Proc Natl Acad Sci USA 1998; 95:4619-4624.
13. Rigotti A, Trigatti BL, Penman M, et al. A targeted mutation in the murine gene encoding the high density lipoprotein (HDL) receptor scavenger receptor class B type I reveals its key role in HDL metabolism. Proc Natl Acad Sci USA 1997; 94:12610-12615.
14. Trigatti B, Rayburn H, Vinals M, et al. Influence of the high density lipoprotein receptor SR-BI on reproductive and cardiovascular pathophysiology. Proc Natl Acad Sci USA 1999; 96:9322-9327.
15. Calvo D, Vega MA. Identification, primary structure, and distribution of CLA-1, a novel member of the CD36/LIMPII gene family. J Biol Chem 1993; 268:18929-18935.
16. Acton S, Osgood D, Donoghue M, et al. Association of polymorphisms at the SR-BI gene locus with plasma lipid levels and body mass index in a white population. Arterioscler Thromb Vasc Biol 1999; 19:1734-1743.
17. Cao G, Garcia CK, Wyne KL, et al. Structure and localization of the human gene encoding SR-BI/CLA-1. Evidence for transcriptional control by steroidogenic factor 1. J Biol Chem 1997; 272:33068-33076.
18. Glass C, Pittman RC, Civen M, Steinberg D. Uptake of high-density lipoprotein-associated apoprotein A-I and cholesterol esters by 16 tissues of the rat in Vivo and by adrenal cells and hepatocytes in Vitro. J Biol Chem 1985; 260:744-750.
19. Pittman RC, Steinberg D. Sites and mechanisms of uptake and degradation of high density and low density lipoproteins. J Lipid Res 1984; 25:1577-1585.
20. Murao K, Terpstra V, Green SR, et al. Characterization of CLA-1, a human homologue of rodent scavenger receptor BI, as a receptor for high density lipoprotein and apoptotic thymocytes. J Biol Chem 1997; 272:17551-17557.
21. Tall AR. Plasma cholesteryl ester transfer protein and high density lipoproteins: new insights from molecular genetic studies. J Intern Med 1995; 237:5-12.
22. Hong SH, Kim YR, Yoon YM, et al. Association between Hae III polymorphism of scavenger receptor class B type I gene and plasma HDL-cholesterol concentration. Ann Clin Biochem 2002; 39:478-481.
23. Le Jossec M, Wambach T, Labuda D, et al. Genetic diversity patterns in the SR-BI/II locus can be explained by a recent selective sweep. Mol Biol Evol 2004; 21:760-769.
24. Osgood D, Corella D, Demissie S, et al. Genetic variation at the scavenger receptor class B type I gene locus determines plasma lipoprotein concentrations and particle size and interacts with type 2 diabetes: the framingham study. J Clin Endocrinol Metab 2003; 88:2869-2879.
25. West M, Greason E, Kolmakova A, et al. Scavenger receptor class B type I protein as an independent predictor of high-density lipoprotein cholesterol levels in subjects with hyperalphalipoproteinemia. J Clin Endocrinol Metab 2009; 94:1451-1457.
26. Roberts CG, Shen H, Mitchell BD, et al. Variants in scavenger receptor class B type I gene are associated with HDL cholesterol levels in younger women. Hum Hered 2007; 64:107-113.
27. Richard E, von Muhlen D, Barrett-Connor E, et al. Modification of the effects of estrogen therapy on HDL cholesterol levels by polymorphisms of the HDL-C receptor, SR-BI: the Rancho Bernardo Study. Atherosclerosis 2005; 180:255-262.
28. Constantineau J, Greason E, West M, et al. A synonymous variant in scavenger receptor, class B, type I gene is associated with lower SR-BI protein expression and function. Atherosclerosis 2010; 210:177-182.
29. McCarthy JJ, Lehner T, Reeves C, et al. Association of genetic variants in the HDL receptor, SR-B1, with abnormal lipids in women with coronary artery disease. J Med Genet 2003; 40:453-458.
30. McCarthy JJ, Lewitzky S, Reeves C, et al. Polymorphisms of the HDL receptor gene associated with HDL cholesterol levels in diabetic kindred from three populations. Hum Hered 2003; 55:163-170.
31. Zhang X, Moor AN, Merkler KA, et al. Regulation of alternative splicing of liver scavenger receptor class B gene by estrogen and the involved regulatory splicing factors. Endocrinology 2007; 148:5295-5304.
32. Graf GA, Roswell KL, Smart EJ. 17beta-Estradiol promotes the up-regulation of SR-BII in HepG2 cells and in rat livers. J Lipid Res 2001; 42:1444-1449.
33. Samsioe G. Cardioprotection by estrogens: mechanisms of action-the lipids. Int J Fertil Menopausal Stud 1994; 39 (Suppl 1):43-49.
34. Stevenson JC, Crook D, Godsland IF. Influence of age and menopause on serum lipids and lipoproteins in healthy women. Atherosclerosis 1993; 98:83-90.
35. Welty FK. Cardiovascular disease and dyslipidemia in women. Arch Intern Med 2001; 161:514-522.
36. Chiba-Falek O, Nichols M, Suchindran S, et al. Impact of gene variants on sex-specific regulation of human Scavenger receptor class B type 1 (SR-BI) expression in liver and association with lipid levels in a population-based study. BMC Med Genet 2010; 11:9.
37. Adorni MP, Zimetti F, Billheimer JT, et al. The roles of different pathways in the release of cholesterol from macrophages. J Lipid Res 2007; 48:2453-2462.
38. Van Eck M, Bos IS, Hildebrand RB, et al. Dual role for scavenger receptor class B, type I on bone marrow-derived cells in atherosclerotic lesion development. Am J Pathol 2004; 165:785-794.
39. Wang X, Collins HL, Ranalletta M, et al. Macrophage ABCA1 and ABCG1, but not SR-BI, promote macrophage reverse cholesterol transport in vivo. J Clin Invest 2007; 117:2216-2224.
40. Yvan-Charvet L, Pagler TA, Wang N, et al. SR-BI inhibits ABCG1-stimulated net cholesterol efflux from cells to plasma HDL. J Lipid Res 2008; 49:107-114.
41. Braun A, Trigatti BL, Post MJ, et al. Loss of SR-BI expression leads to the early onset of occlusive atherosclerotic coronary artery disease, spontaneous myocardial infarctions, severe cardiac dysfunction, and premature death in apolipoprotein E-deficient mice. Circ Res 2002; 90:270-276.
42. Arai T, Rinninger F, Varban L, et al. Decreased selective uptake of high density lipoprotein cholesteryl esters in apolipoprotein E knock-out mice. Proc Natl Acad Sci USA 1999; 96:12050-12055.
43. Kozarsky KF, Donahee MH, Glick JM, et al. Gene transfer and hepatic overexpression of the HDL receptor SR-BI reduces atherosclerosis in the cholesterol-fed LDL receptor-deficient mouse. Arterioscler Thromb Vasc Biol 2000; 20:721-727.
44. Covey SD, Krieger M, Wang W, et al. Scavenger receptor class B type Imediated protection against atherosclerosis in LDL receptor-negative mice involves its expression in bone marrow-derived cells.[see comment]. Arterioscler Thromb Vasc Biol 2003; 23:1589-1594.
45. Zhang W, Yancey PG, Su YR, et al. Inactivation of macrophage scavenger receptor class B type I promotes atherosclerotic lesion development in apolipoprotein E-deficient mice. Circulation 2003; 108:2258-2263.
46. Teslovich TM, Musunuru K, Smith AV, et al. Biological, clinical and population relevance of 95 loci for blood lipids. Nature 2010; 466:707-713.
47. Zhong S, Sharp DS, Grove JS, et al. Increased coronary heart disease in Japanese-American men with mutation in the cholesteryl ester transfer protein gene despite increased HDL levels. J Clin Invest 1996; 97:2917-2923.
48. Rodriguez-Esparragon F, Rodriguez-Perez JC, Hernandez-Trujillo Y, et al. Allelic variants of the human scavenger receptor class B type 1 and paraoxonase 1 on coronary heart disease: genotype-phenotype correlations. Arterioscler Thromb Vasc Biol 2005; 25:854-860.
49. Ritsch A, Sonderegger G, Sandhofer A, et al. Scavenger receptor class B type I polymorphisms and peripheral arterial disease. Metabolism 2007; 56:1135-1141.
50. Fox CS, Cupples LA, Chazaro I, et al. Genomewide linkage analysis for internal carotid artery intimal medial thickness: evidence for linkage to chromosome 12. Am J Hum Genet 2004; 74:253-261.
51. Manichaikul A, Naj AC, Herrington D, et al. Association of SCARB1 variants with subclinical atherosclerosis and incident cardiovascular disease: the multiethnic study of atherosclerosis. Arterioscler Thromb Vasc Biol 2012; 32:1991-1999.
52. Naj AC, West M, Rich SS, et al. Association of scavenger receptor class B type I polymorphisms with subclinical atherosclerosis: the Multi-Ethnic Study of Atherosclerosis. Circ Cardiovasc Genet 2010; 3:47-52.
53. Grallert H, Dupuis J, Bis JC, et al. Eight genetic loci associated with variation in lipoprotein-associated phospholipase A2 mass and activity and coronary heart disease: meta-analysis of genome-wide association studies from five community-based studies. Eur Heart J 2012; 33:238-251.
54. Mineo C, Shaul PW. Functions of scavenger receptor class B, type I in atherosclerosis. Curr Opin Lipidol 2012; 23:487-493.
55. Vergeer M, Korporaal SJ, Franssen R, et al. Genetic variant of the scavenger receptor BI in humans. N Engl J Med 2011; 364:136-145.
56. Tai ES, Adiconis X, Ordovas JM, et al. Polymorphisms at the SRBI locus are associated with lipoprotein levels in subjects with heterozygous familial hypercholesterolemia. Clin Genet 2003; 63:53-58.
57. Morabia A, Ross BM, Costanza MC, et al. Population-based study of SR-BI genetic variation and lipid profile. Atherosclerosis 2004; 175:159-168.
58. Miettinen HE, Rayburn H, Krieger M. Abnormal lipoprotein metabolism and reversible female infertility in HDL receptor (SR-BI)-deficient mice. J Clin Invest 2001; 108:1717-1722.
59. Ji Y, Jian B, Wang N, et al. Scavenger receptor BI promotes high density lipoprotein-mediated cellular cholesterol efflux. J Biol Chem 1997; 272:20982-20985.
60. Jian B, de la Llera-Moya M, Ji Y, et al. Scavenger receptor class B type I as a mediator of cellular cholesterol efflux to lipoproteins and phospholipid acceptors. J Biol Chem 1998; 273:5599-5606.
61. Rothblat GH, de la Llera-Moya M, Atger V, et al. Cell cholesterol efflux: integration of old and new observations provides new insights. J Lipid Res 1999; 40:781-796.
62. Duong M, Collins HL, Jin W, et al. Relative contributions of ABCA1 and SR-BI to cholesterol efflux to serum from fibroblasts and macrophages. Arterioscler Thromb Vasc Biol 2006; 26:541-547.
63. Brunham LR, Tietjen I, Bochem AE, et al. Novel mutations in scavenger receptor BI associated with high HDL cholesterol in humans. Clin Genet 2011; 79:575-581.
64. Chadwick AC, Sahoo D. Functional Characterization of Newly-Discovered Mutations in Human SR-BI. PLoS One 2012; 7:e45660.
65. Connelly MA, de la Llera-Moya M, Monzo P, et al. Analysis of chimeric receptors shows that multiple distinct functional activities of scavenger receptor, class B, type I (SR-BI) are localized to the extracellular receptor domain. Biochemistry 2001; 40:5249-5259.
66. Connelly MA, de la Llera-Moya M, Peng Y, et al. Separation of lipid transport functions by mutations in the extracellular domain of scavenger receptor class B, type I (SR-BI). J Biol Chem 2003; 278:25773-25782.
67. Gu X, Trigatti B, Xu S, et al. The efficient cellular uptake of high density lipoprotein lipids via scavenger receptor class B type I requires not only receptor-mediated surface binding but also receptor-specific lipid transfer mediated by its extracellular domain. J Biol Chem 1998; 273:26338-26348.
68. Temel RE, Trigatti B, DeMattos RB, et al. Scavenger receptor B, type I (SR-BI) is the major route for the delivery of high density lipoprotein cholesterol to the steroidogenic pathway in cultured mouse adrenocortical cells. Proc Natl Acad Sci USA 1997; 94:13600-13605.
69. Arai T, Wang N, Bezouevski M, et al. Decreased atherosclerosis in heterozygous low density lipoprotein receptor-deficient mice expressing the scavenger receptor BI transgene. J Biol Chem 1999; 274:2366-2371.
70. Ueda Y, Gong E, Royer L, et al. Relationship between expression levels and atherogenesis in scavenger receptor class B, type I transgenics. J Biol Chem 2000; 275:20368-20373.
71. Yancey PG, Jerome WG, Yu H, et al. Severely altered cholesterol homeostasis in macrophages lacking apoE and SR-BI. J Lipid Res 2007; 48:1140-1149.
72. Papale GA, Nicholson K, Hanson PJ, et al. Extracellular hydrophobic regions in scavenger receptor BI play a key role in mediating HDL-cholesterol transport. Arch Biochem Biophys 2010; 496:132-139.
73. Sahoo D, Darlington YF, Pop D, et al. Scavenger receptor class B Type I (SR-BI) assembles into detergent-sensitive dimers and tetramers. Biochim Biophys Acta 2007; 1771:807-817.
74. Landschulz KT, Pathak RK, Rigotti A, et al. Regulation of scavenger receptor, class B, type I, a high density lipoprotein receptor, in liver and steroidogenic tissues of the rat. J Clin Invest 1996; 98:984-995.
75. Reaven E, Cortez Y, Leers-Sucheta S, et al. Dimerization of the scavenger receptor class B type I (SR-BI): formation, function and localization in diverse cells and tissues. J Lipid Res 2004; 45:513-528.
76. Gaidukov L, Nager AR, Xu S, et al. Glycine dimerization motif in the N-terminal transmembrane domain of the high density lipoprotein receptor SR-BI required for normal receptor oligomerization and lipid transport. J Biol Chem 2011; 286:18452-18464.
77. Papale GA, Hanson PJ, Sahoo D. Extracellular disulfide bonds support scavenger receptor class B type I-mediated cholesterol transport. Biochemistry 2011; 50:6245-6254.
78. Trigatti BLK. Influence of the HDL receptor SR-BI on lipoprotein metabolism and atherosclerosis. Arterioscler Thromb Vasc Biol 2003; 23:1732-1738.
79. Gwynne J, Strauss III J. The role of lipoproteins in steroidogenesis and cholesterol metabolism in steroigenic glands. Endocr Rev 1982; 3:299-329.
80. Plump AS, Erickson SK, Weng W, et al. Apolipoprotein A-I is required for cholesteryl ester accumulation in steroidogenic cells and for normal adrenal steroid production. J Clin Invest 1996; 97:2660-2671.
81. Hoekstra M, Meurs I, Koenders M, et al. Absence of HDL cholesteryl ester uptake in mice via SR-BI impairs an adequate adrenal glucocorticoidmediated stress response to fasting. J Lipid Res 2008; 49:738-745.
82. Cai L, Ji A, de Beer FC, et al. SR-BI protects against endotoxemia in mice through its roles in glucocorticoid production and hepatic clearance. J Clin Invest 2008; 118:364-375.
83. Illingworth DR, Lees AM, Lees RS. Adrenal cortical function in homozygous familial hypercholesterolemia. Metab Clin Exper 1983; 32:1045-1052.
84. Allen JM, Thompson GR, Myant NB. Normal adrenocortical response to adrenocorticotrophic hormone in patients with homozygous familial hypercholesterolaemia. Clin Sci 1983; 65:99-101.
85. Illingworth DR, Kenny TA, Orwoll ES. Adrenal function in heterozygous and homozygous hypobetalipoproteinemia. J Clin Endocrinol Metab 1982; 54:27-33.
86. Cole TJ, Harris HJ, Hoong I, et al. The glucocorticoid receptor is essential for maintaining basal and dexamethasone-induced repression of the murine corticosteroid-binding globulin gene. Mol Cell Endocrinol 1999; 154:29-36.
87. Smith CL, Hammond GL. Hormonal regulation of corticosteroid-binding globulin biosynthesis in the male rat. Endocrinology 1992; 130:2245-2251.
88. Lacoste L, Lam JY, Hung J, et al. Hyperlipidemia and coronary disease. Correction of the increased thrombogenic potential with cholesterol reduction. Circulation 1995; 92:3172-3177.
89. Stuart MJ, Gerrard JM, White JG. Effect of cholesterol on production of thromboxane b2 by platelets in vitro. N Engl J Med 1980; 302:6-10.
90. Trip MD, Cats VM, van Capelle FJ, Vreeken J. Platelet hyperreactivity and prognosis in survivors of myocardial infarction. N Engl J Med 1990; 322:1549-1554.
91. Sobel BE, Schneider DJ. Platelet function, coagulopathy, and impaired fibrinolysis in diabetes. Cardiol Clin 2004; 22:511-526.
92. Dole VS, Matuskova J, Vasile E, et al. Thrombocytopenia and platelet abnormalities in high-density lipoprotein receptor-deficient mice. Arterioscler Thromb Vasc Biol 2008; 28:1111-1116.
93. El Bouhassani M, Gilibert S, Moreau M, et al. Cholesteryl ester transfer protein expression partially attenuates the adverse effects of SR-BI receptor deficiency on cholesterol metabolism and atherosclerosis. J Biol Chem 2011; 286:17227-17238.
94. Ma Y, Ashraf MZ, Podrez EA. Scavenger receptor BI modulates platelet reactivity and thrombosis in dyslipidemia. Blood 2010; 116:1932-1941.
95. Carvalho AC, Colman RW, Lees RS. Platelet function in hyperlipoproteinemia. N Engl J Med 1974; 290:434-438.
96. Heemskerk JW, Feijge MA, Simonis MA, Hornstra G. Effects of dietary fatty acids on signal transduction and membrane cholesterol content in rat platelets. Biochim Biophys Acta 1995; 1255:87-97.
97. Shattil SJ, Anaya-Galindo R, Bennett J, et al. Platelet hypersensitivity induced by cholesterol incorporation. J Clin Invest 1975; 55:636-643.
98. Brodde MF, Korporaal SJ, Herminghaus G, et al. Native high-density lipoproteins inhibit platelet activation via scavenger receptor BI: role of negatively charged phospholipids. Atherosclerosis 2011; 215:374-382.
99. Sinzinger H, Pirich C, Bednar J, O'Grady J. Ex-vivo and in-vivo platelet function in patients with severe hypercholesterolemia undergoing LDLapheresis. Thromb Res 1996; 82:291-301.
100. Imachi H, Murao K, Cao W, et al. Expression of human scavenger receptor B1 on and in human platelets. Arterioscler Thromb Vasc Biol 2003; 23:898-904.
101. Burger PC, Wagner DD. Platelet P-selectin facilitates atherosclerotic lesion development. Blood 2003; 101:2661-2666.
102. Huo Y, Schober A, Forlow SB, et al. Circulating activated platelets exacerbate atherosclerosis in mice deficient in apolipoprotein E. Nat Med 2003; 9:61-67.
103. Kabbani SS, Watkins MW, Ashikaga T, et al. Platelet reactivity characterized prospectively: a determinant of outcome 90 days after percutaneous coronary intervention. Circulation 2001; 104:181-186.
104. Hatzopoulos AK, Rigotti A, Rosenberg RD, Krieger M. Temporal and spatial pattern of expression of the HDL receptor SR-BI during murine embryogenesis. J Lipid Res 1998; 39:495-508.
105. Wyne KL, Woollett LA. Transport of maternal LDL and HDL to the fetal membranes and placenta of the Golden Syrian hamster is mediated by receptor-dependent and receptor-independent processes. J Lipid Res 1998; 39:518-530.
106. Ng DS, Francone OL, Forte TM, et al. Disruption of the murine lecithin:cholesterol acyltransferase gene causes impairment of adrenal lipid delivery and up-regulation of scavenger receptor class B type I. J Biol Chem 1997; 272:15777-15781.
107. Meiner VL, Cases S, Myers HM, et al. Disruption of the acyl-CoA:cholesterol acyltransferase gene in mice: evidence suggesting multiple cholesterol esterification enzymes in mammals. Proc Natl Acad Sci USA 1996; 93:14041-14046.
108. Yesilaltay A, Morales MG, Amigo L, et al. Effects of hepatic expression of the high-density lipoprotein receptor SR-BI on lipoprotein metabolism and female fertility. Endocrinology 2006; 147:1577-1588.
109. Velasco M, Alexander C, King J, et al. Association of lower plasma estradiol levels and low expression of scavenger receptor class B, type I in infertile women. Fertil Steril 2006; 85:1391-1397.
110. Kolmakova A, Wang J, Brogan R, et al. Deficiency of scavenger receptor class B type I negatively affects progesterone secretion in human granulosa cells. Endocrinology 2010; 151:5519-5527.
111. Yates M, Kolmakova A, Zhao Y, Rodriguez A. Clinical impact of scavenger receptor class B type I gene polymorphisms on human female fertility. Hum Reprod 2011; 26:1910-1916.
112. Jimenez LM, Binelli M, Bertolin K, et al. Scavenger receptor-B1 and luteal function in mice. J Lipid Res 2010; 51:2362-2371.
113. Gordon DJ, Rifkind BM. High-density lipoprotein: the clinical implications of recent studies. [Review] [52 refs]. N Engl J Med 1989; 321:1311-1316.
114. Van Eck M. Differential effects of scavenger receptor BI deficiency on lipid metabolism in cells of the arterial wall and in the liver. J Biol Chem 2003; 278:23699-23705.
115. Joy T, Hegele RA. Is raising HDL a futile strategy for atheroprotection? Nat Rev Drug Discov 2008; 7:143-155.
116. Athyros VG, Katsiki N, Karagiannis A, Mikhailidis DP. Should raising highdensity lipoprotein cholesterol be a matter of debate? J Cardiovasc Med (Hagerstown) 2012; 13:254-259.
117. Stylianou IM, Bauer RC, Reilly MP, Rader DJ. Genetic basis of atherosclerosis: insights from mice and humans. Circ Res 2012; 110:337-355.
118. Voight BF, Peloso GM, Orho-Melander M, et al. Plasma HDL cholesterol and risk of myocardial infarction: a mendelian randomisation study. Lancet 2012; 380:572-580.
119. Mineo C, Shaul PW. HDL stimulation of endothelial nitric oxide synthase: a novel mechanism of HDL action. Trends Cardiovasc Med 2003; 13:226-231.
120. Mineo C, Shaul PW. Role of high-density lipoprotein and scavenger receptor B type I in the promotion of endothelial repair. Trends Cardiovasc Med 2007; 17:156-161.
121. Hewing B, Fisher EA. Rationale for cholesteryl ester transfer protein inhibition. Curr Opin Lipidol 2012; 23:372-376.
122. Degoma EM, Rader DJ. Novel HDL-directed pharmacotherapeutic strategies. Nat Rev Cardiol 2011; 8:266-277.